DNAP markets forensic and recreational genomics testing products. Also,
DNAPrint genomics, Inc. uses proprietary human genome research methods and has
developed predictive tests for drug response. These tests allow "personalized
medicine," matching patients with drugs based on their genetic constitution
and predicted response. The Company also discovers disease genes for the
development of new drugs. DNAPrint genomics is traded on the Nasdaq OTC
Bulletin Board under the ticker symbol: DNAP. For more information about the
company, please visit http://www.dnaprint.com.
